{{Rsnum
|rsid=2959656
|Gene=MEN1
|Chromosome=11
|position=64804546
|Orientation=minus
|ReferenceAllele=G
|MissenseAllele=A
|GMAF=0.1543
|Gene_s=MAP4K2,MEN1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 1.8 | 98.2
| HCB | 9.0 | 28.4 | 62.7
| JPT | 7.3 | 37.6 | 55.0
| YRI | 11.6 | 46.3 | 42.2
| ASW | 5.3 | 45.6 | 49.1
| CHB | 9.0 | 28.4 | 62.7
| CHD | 6.6 | 33.0 | 60.4
| GIH | 0.0 | 0.0 | 0.0
| LWK | 7.3 | 42.2 | 50.5
| MEX | 0.0 | 25.9 | 74.1
| MKK | 5.1 | 40.4 | 54.5
| TSI | 0.0 | 2.0 | 98.0
| HapMapRevision=28
}}{{Venter SNP
|rsid=2959656
|allele=C
|frequency=
|uid=1103649707660
|type=homozygous_SNP
|hugo=MEN1
|ensembl gene=ENSG00000133895
|ensembl transcript=ENST00000312049
|sift=TOLERATED
|disease=Defects in MEN1 are the cause of familial isolated hyperparathyroidism (FIHP) (MIM:145000); also designated HRPT1. FIHP is an autosomal dominant disorder characterized by hypercalcemia, elevated parathyroid hormone (PTH) levels, and uniglandular or multiglandular parathyroid tumors.
}}

{{GET Evidence
|gene=MEN1
|aa_change=Thr546Ala
|aa_change_short=T546A
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2959656
|overall_frequency_n=9765
|overall_frequency_d=10758
|overall_frequency=0.907697
|n_genomes=51
|n_genomes_annotated=0
|n_haplomes=89
|n_articles=0
|n_articles_annotated=0
|qualityscore_in_silico=4
|qualitycomment_in_silico=Y
|gene_in_genetests=Y
|genetests_testable=Y
|genetests_reviewed=Y
|nblosum100=1
|autoscore=3
|n_web_uneval=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}